One critical incentive for ongoing drug discovery and development is the temporary monopoly pricing that manufacturers can command for novel drugs. Yet this incentive, embedded in current patent and regulatory policy, does not guarantee that manufacturers
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/04/16/new-cures-require-new-pricing-policies/
Posted
Apr 16 2015, 06:00 AM
by
Health Affairs Blog